Lipoproteins and Cardiovascular Health

Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

The MOS 36-Item Short-Form Health Survey (SF-36)

A 12-Item Short-Form Health Survey

Health Behavior and Health Education: Theory, Research, and Practice

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

EuroQol - a new facility for the measurement of health-related quality of life

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

Nudge: improving decisions about health, wealth, and happiness

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: Conceptual issues and research evidence.

Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science

Crossing the Quality Chasm: A New Health System for the 21st Century

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

To Err is Human: Building a Safer Health System

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization